BREAKING: $JNJ reports quarterly results
-EPS $2.30 Adj. vs $2.00 Est.
-Revenue: $20.69B vs. $19.48B Est.

"We think our pharmaceutical and consumer business will be on par," says CFO Joe Wolk. "Where we are taking down our guidance is really in the medical device unit." https://t.co/dcK5OEcmxv